Creo Medical Valuation
| CREO Stock | 13.13 0.25 1.94% |
At this time, the firm appears to be undervalued. Creo Medical Group shows a prevailing Real Value of USD14.84 per share. The current price of the firm is USD13.13. Our model approximates the value of Creo Medical Group from analyzing the firm fundamentals such as profit margin of (0.74) %, and Return On Equity of -0.38 as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.1421 | Enterprise Value 58.5 M | Enterprise Value Ebitda (2.27) | Price Sales 1.7867 | Enterprise Value Revenue 1.9319 |
Undervalued
Today
Please note that Creo Medical's price fluctuation is not too volatile at this time. Calculation of the real value of Creo Medical Group is based on 3 months time horizon. Increasing Creo Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Creo stock is determined by what a typical buyer is willing to pay for full or partial control of Creo Medical Group. Since Creo Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Creo Stock. However, Creo Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.13 | Real 14.84 | Hype 13.41 | Naive 14.23 |
The intrinsic value of Creo Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Creo Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Creo Medical Group helps investors to forecast how Creo stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Creo Medical more accurately as focusing exclusively on Creo Medical's fundamentals will not take into account other important factors: Creo Medical Cash |
|
Creo Medical Total Value Analysis
Creo Medical Group is currently projected to have takeover price of 58.54 M with market capitalization of 54.14 M, debt of 8.3 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Creo Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
58.54 M | 54.14 M | 8.3 M |
Creo Medical Investor Information
About 16.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.14. Some equities with similar Price to Book (P/B) outperform the market in the long run. Creo Medical Group recorded a loss per share of 0.06. The entity had not issued any dividends in recent years. Creo Medical Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Creo Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Creo Medical has an asset utilization ratio of 40.21 percent. This implies that the Company is making USD0.4 for each dollar of assets. An increasing asset utilization means that Creo Medical Group is more efficient with each dollar of assets it utilizes for everyday operations.Creo Medical Ownership Allocation
Creo Medical holds a total of 412.47 Million outstanding shares. 30% of Creo Medical Group outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Creo Medical Profitability Analysis
The company reported the revenue of 30.8 M. Net Loss for the year was (21.7 M) with profit before overhead, payroll, taxes, and interest of 15 M.About Creo Medical Valuation
The stock valuation mechanism determines Creo Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Creo Medical Group based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Creo Medical. We calculate exposure to Creo Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Creo Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 17.6 M | 18.5 M |
Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.